Ezaki, T., Tanaka, T., Tamura, R., Ohara, K., Yamamoto, Y., Takei, J., . . . Sasaki, H. (2024). Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment. Brain Tumor Pathology, 41(2), 61-72. https://doi.org/10.1007/s10014-024-00481-0
Chicago-referens (17:e uppl.)Ezaki, Taketo, et al. "Status of Alternative Angiogenic Pathways in Glioblastoma Resected Under and After Bevacizumab Treatment." Brain Tumor Pathology 41, no. 2 (2024): 61-72. https://doi.org/10.1007/s10014-024-00481-0.
MLA-referens (9:e uppl.)Ezaki, Taketo, et al. "Status of Alternative Angiogenic Pathways in Glioblastoma Resected Under and After Bevacizumab Treatment." Brain Tumor Pathology, vol. 41, no. 2, 2024, pp. 61-72, https://doi.org/10.1007/s10014-024-00481-0.
